Human Metabolome Technologies, Inc. (6090.T)

JPY 604.0

(0.0%)

Market Cap (In JPY)

3.57 Billion

Revenue (In JPY)

1.34 Billion

Net Income (In JPY)

243.24 Million

Avg. Volume

8768.00

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
501.0-720.0
PE
-
EPS
-
Beta Value
0.511
ISIN
JP3794530000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Yasuhiro Ohata
Employee Count
-
Website
https://www.humanmetabolome.com
Ipo Date
2014-01-21
Details
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is based in Tsuruoka, Japan.